These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 33719170

  • 21. Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases.
    Horai Y, Isomoto E, Koga T, Okada A, Kawashiri SY, Tamai M, Yamasaki S, Nakamura H, Origuchi T, Hamaguchi Y, Fujimoto M, Kuwana M, Kawakami A.
    Mod Rheumatol; 2013 Jan; 23(1):190-4. PubMed ID: 22460910
    [Abstract] [Full Text] [Related]

  • 22. Case Report: Concurrence of Dermatomyositis and Autoimmune Blistering Diseases: Two Case Reports and a Literature Review.
    Wu H, Diao L, Xue K, Zhao Q, Zhao X, Xia Q, Zheng J, Pan M, Cao H.
    Front Immunol; 2022 Jan; 13():855408. PubMed ID: 35401576
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis.
    Vuppala A, Sondhi M, Umer S.
    Pediatr Rheumatol Online J; 2023 Dec 20; 21(1):147. PubMed ID: 38124190
    [Abstract] [Full Text] [Related]

  • 25. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.
    González-Moreno J, Raya-Cruz M, Losada-Lopez I, Cacheda AP, Oliver C, Colom B.
    Rheumatol Int; 2018 Jul 20; 38(7):1293-1296. PubMed ID: 29417209
    [Abstract] [Full Text] [Related]

  • 26. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
    Ikeda S, Arita M, Misaki K, Mishima S, Takaiwa T, Nishiyama A, Ito A, Furuta K, Yokoyama T, Tokioka F, Noyama M, Yoshioka H, Ishida T.
    Springerplus; 2015 Jul 20; 4():240. PubMed ID: 26101728
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies.
    Okiyama N, Fujimoto M.
    F1000Res; 2019 Jul 20; 8():. PubMed ID: 31824645
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y, Fu Q, Wang R, Guo Q, Bao C.
    J Clin Lab Anal; 2019 Oct 20; 33(8):e22978. PubMed ID: 31301087
    [Abstract] [Full Text] [Related]

  • 31. Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective database.
    Pandya R, Kleitsch J, Lim D, Werth VP.
    J Am Acad Dermatol; 2024 Jul 20; 91(1):31-36. PubMed ID: 38342246
    [Abstract] [Full Text] [Related]

  • 32. [Response of dermatomyositis with lung involvement to Janus kinase inhibitor treatment].
    Hornig J, Weinhage T, Schmidt LH, Buerke B, Schneider U, Pavenstädt H, Becker H, Gabriëls G.
    Z Rheumatol; 2018 Dec 20; 77(10):952-957. PubMed ID: 30421033
    [Abstract] [Full Text] [Related]

  • 33. Cutaneous Features of Anti-MDA-5 Antibody-Positive Amyopathic Dermatomyositis in a Sudanese Patient.
    Alqahtani N, Aleissa M.
    Case Rep Dermatol; 2021 Dec 20; 13(3):481-485. PubMed ID: 34720922
    [Abstract] [Full Text] [Related]

  • 34. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].
    Girard C, Vincent T, Bessis D.
    Ann Dermatol Venereol; 2013 Oct 20; 140(10):628-34. PubMed ID: 24090894
    [Abstract] [Full Text] [Related]

  • 35. A systematic review of juvenile-onset clinically amyopathic dermatomyositis.
    Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD.
    Br J Dermatol; 2007 Oct 20; 157(4):637-44. PubMed ID: 17596148
    [Abstract] [Full Text] [Related]

  • 36. [Autoantibodies specifically detected in patients with polymyositis/dermatomyositis].
    Sato S.
    Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr 20; 29(2):85-93. PubMed ID: 16651706
    [Abstract] [Full Text] [Related]

  • 37. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody.
    Cao H, Pan M, Kang Y, Xia Q, Li X, Zhao X, Shi R, Lou J, Zhou M, Kuwana M, Ding X, Zheng J.
    Arthritis Care Res (Hoboken); 2012 Oct 20; 64(10):1602-10. PubMed ID: 22623119
    [Abstract] [Full Text] [Related]

  • 38. Gottron Papules and Gottron Sign with Ulceration: A Distinctive Cutaneous Feature in a Subset of Patients with Classic Dermatomyositis and Clinically Amyopathic Dermatomyositis.
    Cao H, Xia Q, Pan M, Zhao X, Li X, Shi R, Zhou M, Ding X, Kuwana M, Zheng J.
    J Rheumatol; 2016 Sep 20; 43(9):1735-42. PubMed ID: 27307530
    [Abstract] [Full Text] [Related]

  • 39. [The Diagnosis is Obvious].
    Fisser C, Wiest C, Hamer OW, Müller T, Lubnow M, Pfeifer M, Lerzer C, Dvorak I.
    Pneumologie; 2020 Nov 20; 74(11):780-786. PubMed ID: 32663889
    [Abstract] [Full Text] [Related]

  • 40. Clinical Characteristics and Management of Patients With Clinical Amyopathic Dermatomyositis: A Retrospective Study of 64 Patients at a Tertiary Dermatology Department.
    Tang K, Zhang H, Jin H.
    Front Med (Lausanne); 2021 Nov 20; 8():783416. PubMed ID: 34926528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.